Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events-Reference-Cited by-同舟云学术

Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events

Published:2010-01-20 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Cates Christopher J¹,Lasserson Toby J²

Affiliation:

1. St George's University of London; Population Health Sciences and Education; Cranmer Terrace London UK SW17 0RE

2. The Cochrane Collaboration; Cochrane Editorial Unit; 11-13 Cavendish Square London UK W1G 0AN

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD007694.pub2/fullpdf

Reference77 articles.

1. Aalbers R Fixed or adjustable maintenance-dose budesonide/formoterol compared with fixed maintenance-dose salmeterol fluticasone propionate in asthma patients aged [greater-than or equal to]16 years: post hoc analysis of a randomized, double-blind open-label extension, parallel-group study Clinical Drug Investigation 2010 439 51

2. Aalbers R Backer V Kava TT Welte T Omenaas ER Bergqvist PBF Adjustable dosing with budesonide/formoterol reduces the rate of asthma exacerbations compared with fixed dosing salmeterol/fluticasone European Respiratory Society 2003 2 20

3. Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma;Aalbers;Current Medical Research & Opinion,2004

4. Adjustable dosing with budesonide/formoterol achieves sustained guideline ‘well-controlled asthma‘ following step down in treatment;Aalbers;European Respiratory Journal,2005

5. Aalbers R Welte T Jorup C Adjustable maintenance dosing (AMD) with budesonide /formoterol (B/F) meets guideline-defined management goals more effectively than fixed dosing (FD) with B/F or salmeterol/fluticasone (S/FL) [Abstract] European Respiratory Journal 2004 311s

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting of KOR by famotidine promotes OPC maturation differentiation and CNS remyelination via STAT3 signaling pathway;International Journal of Biological Macromolecules;2024-06

2. The Wiser Strategy of Using Beta-Agonists in Asthma: Mechanisms and Rationales;Allergy, Asthma & Immunology Research;2024

3. Efficacy of β2-adrenergic receptor agonist combined with corticosteroid in the treatment of children with cough variant asthma;World Journal of Clinical Cases;2023-11-06

4. New approaches in childhood asthma treatment;Current Opinion in Allergy & Clinical Immunology;2023-06-23

5. Regular formoterol plus inhaled corticosteroid vs. salmeterol plus inhaled corticosteroid for asthma;Clinical & Experimental Allergy;2023-04-16